You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

EXPLORE THE COMPASS GROUP

Compass Associates

Multi-award-winning recruitment consultancy dedicated to the independent Health, Social Care and Children's Services sectors.

Compass Executives

Dedicated Executive Search services for Health, Social Care, Children's Services & Education and Life Sciences. Covering the UK, International Investor, Advisory Services and Private Business sectors.

Compass Corporate Services

Recruitment solutions with full coverage of HR, Finance & Accounting, Marketing & Communications and Property & Estates for the independent Health and Social Care markets.

Cancer Clinical Trials – how they have evolved and what we can expect in the future

In 2023, World Cancer Day looks at highlighting the progress that has been made so far with cancer treatment. In this article, Compass Life Sciences looks at diversity representation within...

News

AZ, Daiichi Sankyo’s Enhertu wins US approval for HER2-positive gastric cancer

AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval in the US for the treatment of locally advanced/metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma.